Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Zinc deficiency promotes endothelin secretion and endothelial cell migration through nuclear hypoxia-inducible factor-1 translocation.

Morand J, Briançon-Marjollet A, Lemarie E, Gonthier B, Arnaud J, Korichneva I, Godin-Ribuot D.

Am J Physiol Cell Physiol. 2019 Aug 1;317(2):C270-C276. doi: 10.1152/ajpcell.00460.2018. Epub 2019 May 22.

PMID:
31116583
2.

Chronic neuromuscular electrical stimulation improves muscle mass and insulin sensitivity in a mouse model.

Lotri-Koffi A, Pauly M, Lemarié E, Godin-Ribuot D, Tamisier R, Pépin JL, Vivodtzev I.

Sci Rep. 2019 May 10;9(1):7252. doi: 10.1038/s41598-019-43696-4.

3.

Nonmuscle Myosin Light Chain Kinase: A Key Player in Intermittent Hypoxia-Induced Vascular Alterations.

Arnaud C, Bouyon S, Recoquillon S, Brasseur S, Lemarié E, Briançon-Marjollet A, Gonthier B, Toral M, Faury G, Martinez MC, Andriantsitohaina R, Pepin JL.

J Am Heart Assoc. 2018 Jan 25;7(3). pii: e007893. doi: 10.1161/JAHA.117.007893.

4.

An innovative intermittent hypoxia model for cell cultures allowing fast Po2 oscillations with minimal gas consumption.

Minoves M, Morand J, Perriot F, Chatard M, Gonthier B, Lemarié E, Menut JB, Polak J, Pépin JL, Godin-Ribuot D, Briançon-Marjollet A.

Am J Physiol Cell Physiol. 2017 Oct 1;313(4):C460-C468. doi: 10.1152/ajpcell.00098.2017. Epub 2017 Jul 26.

5.

Endoplasmic reticulum stress as a novel inducer of hypoxia inducible factor-1 activity: its role in the susceptibility to myocardial ischemia-reperfusion induced by chronic intermittent hypoxia.

Belaidi E, Thomas A, Bourdier G, Moulin S, Lemarié E, Levy P, Pépin JL, Korichneva I, Godin-Ribuot D, Arnaud C.

Int J Cardiol. 2016 May 1;210:45-53. doi: 10.1016/j.ijcard.2016.02.096. Epub 2016 Feb 17.

PMID:
26922713
6.

Gastroesophageal reflux disease is a risk factor for severity of organizing pneumonia.

Gaillet G, Favelle O, Guilleminault L, de Muret A, Lemarie E, Lecomte T, Marchand-Adam S, Diot P.

Respiration. 2015;89(2):119-26. doi: 10.1159/000369470. Epub 2015 Jan 28.

7.

VEGF neutralizing aerosol therapy in primary pulmonary adenocarcinoma with K-ras activating-mutations.

Hervé V, Rabbe N, Guilleminault L, Paul F, Schlick L, Azzopardi N, Duruisseaux M, Fouquenet D, Montharu J, Redini F, Paintaud G, Lemarié E, Cadranel J, Wislez M, Heuzé-Vourc'h N.

MAbs. 2014;6(6):1638-48. doi: 10.4161/mabs.34454.

8.

Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system.

Guilleminault L, Azzopardi N, Arnoult C, Sobilo J, Hervé V, Montharu J, Guillon A, Andres C, Herault O, Le Pape A, Diot P, Lemarié E, Paintaud G, Gouilleux-Gruart V, Heuzé-Vourc'h N.

J Control Release. 2014 Dec 28;196:344-54. doi: 10.1016/j.jconrel.2014.10.003. Epub 2014 Oct 17.

PMID:
25451545
9.

Altered in vitro endothelial repair and monocyte migration in obstructive sleep apnea: implication of VEGF and CRP.

Briançon-Marjollet A, Henri M, Pépin JL, Lemarié E, Lévy P, Tamisier R.

Sleep. 2014 Nov 1;37(11):1825-32. doi: 10.5665/sleep.4180.

10.

Prevalence of malnutrition and current use of nutrition support in patients with cancer.

Hébuterne X, Lemarié E, Michallet M, de Montreuil CB, Schneider SM, Goldwasser F.

JPEN J Parenter Enteral Nutr. 2014 Feb;38(2):196-204. doi: 10.1177/0148607113502674.

PMID:
24748626
11.

[Individual lung cancer screening in practice. Perspectives on the propositions from the multidisciplinary group of the Intergroupe francophone de cancérologie thoracique, the Société d'imagerie thoracique and the Groupe d'oncologie de langue française].

Girard N, Gounant V, Mennecier B, Greillier L, Cortot AB, Couraud S, Besse B, Brouchet L, Castelnau O, Ferretti GR, Frappé P, Khalil A, Lefebure P, Laurent F, Liebart S, Margery J, Molinier O, Quoix E, Revel MP, Stach B, Souquet PJ, Thomas P, Trédaniel J, Lemarié E, Zalcman G, Barlési F, Milleron B; groupe de travail multidisciplinaire de l’Intergroupe francophone de cancérologie thoracique, de la Société d’imagerie thoracique et du Groupe d’oncologie de langue française.

Rev Mal Respir. 2014 Jan;31(1):91-103. doi: 10.1016/j.rmr.2013.10.641. Epub 2014 Jan 10. French. No abstract available.

PMID:
24461451
12.

A randomised trial comparing preoperative to perioperative chemotherapy in early-stage non-small-cell lung cancer (IFCT 0002 trial).

Westeel V, Quoix E, Puyraveau M, Lavolé A, Braun D, Laporte S, Bigay-Game L, Pujol JL, Ozenne G, Rivière A, Douillard JY, Lebeau B, Debieuvre D, Poudenx M, David P, Molinier O, Zalcman G, Lemarié E, Morin F, Depierre A, Milleron B; Intergroupe Francophone de Cancérologie Thoracique.

Eur J Cancer. 2013 Aug;49(12):2654-64. doi: 10.1016/j.ejca.2013.04.013. Epub 2013 Jun 1.

PMID:
23735703
13.

[From the NLST randomized trial to the clinic: how should we implement individual lung cancer screening in clinical practice?].

Couraud S, Barlési F, Lemarié E, Zalcman G, Milleron B; pour le groupe de travail IFCT/GOLF sur le dépistage du cancer broncho-pulmonaire.

Rev Mal Respir. 2013 Jan;30(1):15-7. doi: 10.1016/j.rmr.2012.10.021. Epub 2012 Nov 22. French. No abstract available.

PMID:
23318184
14.

From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue francaise (GOLF).

Couraud S, Cortot AB, Greillier L, Gounant V, Mennecier B, Girard N, Besse B, Brouchet L, Castelnau O, Frappé P, Ferretti GR, Guittet L, Khalil A, Lefebure P, Laurent F, Liebart S, Molinier O, Quoix E, Revel MP, Stach B, Souquet PJ, Thomas P, Trédaniel J, Lemarié E, Zalcman G, Barlési F, Milleron B; French lung cancer screening statement taskforce; groupe d'Oncologie de langue française.

Ann Oncol. 2013 Mar;24(3):586-97. doi: 10.1093/annonc/mds476. Epub 2012 Nov 7.

15.

[Management, substitutive therapy and withdrawal: tobacco, alcohol, psycho-active and illicit substances. Tobacco addiction].

Dansou A, Maino B, Lemarié E.

Rev Prat. 2012 Jun;62(6):837-41. Review. French. No abstract available.

PMID:
22838288
16.

[Lung cancer in adults: Better prognosis of patients aged 45 and under related to good condition and lower TNM stage (a comparative and retrospective study)].

Marquette D, Pichon E, Deschasse G, Lemaire B, Lemarie E, Diot P, Marchand-Adam S.

Presse Med. 2012 Jun;41(6 Pt 1):e250-6. doi: 10.1016/j.lpm.2011.11.025. Epub 2012 Feb 4. French.

PMID:
22305618
17.

[Epidemiological novelties in lung cancer].

Quoix E, Lemarié E.

Rev Mal Respir. 2011 Oct;28(8):1048-58. doi: 10.1016/j.rmr.2010.12.015. Epub 2011 Nov 1. Review. French.

PMID:
22099410
18.

[Multidisciplinary meetings in oncology do not impact the physician-patient relationship].

Orgerie MB, Duchange N, Pélicier N, Rosset P, Lemarié E, Dorval E, Chapet S, Hervé C, Moutel G.

Presse Med. 2012 Mar;41(3 Pt 1):e87-94. doi: 10.1016/j.lpm.2011.07.026. Epub 2011 Nov 12. French.

19.

Aerosolized gemcitabine in patients with carcinoma of the lung: feasibility and safety study.

Lemarie E, Vecellio L, Hureaux J, Prunier C, Valat C, Grimbert D, Boidron-Celle M, Giraudeau B, le Pape A, Pichon E, Diot P, el Houfia A, Gagnadoux F.

J Aerosol Med Pulm Drug Deliv. 2011 Dec;24(6):261-70. doi: 10.1089/jamp.2010.0872. Epub 2011 Jul 27.

PMID:
21793717
20.

Phase I and pharmacokinetic study of IV vinflunine in combination with gemcitabine for treatment of advanced non-small cell lung cancer in Chemonaive patients.

Tournoux-Facon C, Senellart H, Lemarie E, Tourani JM, Favrel S, Pouget JC, Pinel MC, Bennouna J.

J Thorac Oncol. 2011 Jul;6(7):1247-53. doi: 10.1097/JTO.0b013e31821b0f3b.

21.

The airways, a novel route for delivering monoclonal antibodies to treat lung tumors.

Maillet A, Guilleminault L, Lemarié E, Lerondel S, Azzopardi N, Montharu J, Congy-Jolivet N, Reverdiau P, Legrain B, Parent C, Douvin DH, Hureaux J, Courty Y, De Monte M, Diot P, Paintaud G, Le Pape A, Watier H, Heuzé-Vourc'h N.

Pharm Res. 2011 Sep;28(9):2147-56. doi: 10.1007/s11095-011-0442-5. Epub 2011 Apr 14.

PMID:
21491145
22.

[The Respiratory Research Fund, year 2010].

Lemarié E, Similowski T.

Rev Mal Respir. 2011 Mar;28(3):273-6. doi: 10.1016/j.rmr.2011.02.001. Epub 2011 Mar 12. French. No abstract available.

PMID:
21482327
23.

Defining the clinical condition of cancer patients: it is time to switch from performance status to nutritional status.

Cessot A, Hebuterne X, Coriat R, Durand JP, Mir O, Mateus C, Cacheux W, Lemarie E, Michallet M, de Montreuil CB, Goldwasser F; French Nutrition Oncology Study Group.

Support Care Cancer. 2011 Jul;19(7):869-70. doi: 10.1007/s00520-011-1122-z. Epub 2011 Mar 10. No abstract available.

PMID:
21387161
24.

[Sleep apnea syndrome: clinical practice guidelines].

Lemarié E, Valeyre D, Housset B, Godard P.

Rev Mal Respir. 2010 Sep;27(7):804-5. doi: 10.1016/j.rmr.2010.06.004. Epub 2010 Jul 31. French. No abstract available.

PMID:
20863986
25.

[New recommendations for the management of COPD].

Lemarié E, Valeyre D, Housset B.

Rev Mal Respir. 2010 May;27(5):520-1. doi: 10.1016/j.rmr.2010.04.012. French. No abstract available.

PMID:
20569888
26.

[2010: world year of the lung].

Lemarié E, Valeyre D.

Rev Mal Respir. 2010;27(1):3-4. doi: 10.1016/j.rmr.2009.11.011. Epub 2009 Dec 30. French. No abstract available.

PMID:
20146944
27.

[Clinical practice guidelines: SPLF keeps its pace].

Didier A, Lemarié E.

Rev Mal Respir. 2009 Nov;26(9):919-21. French. No abstract available.

PMID:
19953037
28.

[Lung cancers. One out of ten new cases of cancer in France].

Lemarié E.

Rev Prat. 2009 Sep 20;59(7):917-9. French. No abstract available.

PMID:
19839456
29.

[Decision process in oncology: the importance of multidisciplinary meeting].

Orgerie MB, Duchange N, Pélicier N, Chapet S, Dorval E, Rosset P, Lemarié E, Hervé C, Moutel G.

Bull Cancer. 2010 Feb;97(2):255-64. doi: 10.1684/bdc.2009.0957. French.

30.

Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN.

Regina S, Valentin JB, Lachot S, Lemarié E, Rollin J, Gruel Y.

Clin Chem. 2009 Oct;55(10):1834-42. doi: 10.1373/clinchem.2009.123695. Epub 2009 Aug 6.

31.

[Levels of proof for guidelines. Report of the French Language Society of Pneumology].

Marchand-Adam S, Thabut G, Cadranel J, Bonniaud P, Didier A, Roche N, Bonay M, Lemarié E; ; le Conseil Scientifique de la SPLF.

Rev Mal Respir. 2008 Nov;25(9):1081-6. French. No abstract available.

PMID:
19106903
32.

Aerosolized chemotherapy.

Gagnadoux F, Hureaux J, Vecellio L, Urban T, Le Pape A, Valo I, Montharu J, Leblond V, Boisdron-Celle M, Lerondel S, Majoral C, Diot P, Racineux JL, Lemarie E.

J Aerosol Med Pulm Drug Deliv. 2008 Mar;21(1):61-70. doi: 10.1089/jamp.2007.0656. Review.

PMID:
18518832
33.

[Stage IV non small cell bronchial carcinoma; first line therapy in 2007].

Lemarié E.

Rev Mal Respir. 2007 Oct;24(8 Pt 2):6S101-7. Review. French.

PMID:
18235401
34.

[You said"ground glass"?].

Lemarié E.

Rev Mal Respir. 2007 Dec;24(10):1255-6. French. No abstract available.

PMID:
18216745
35.

Aerodynamical, immunological and pharmacological properties of the anticancer antibody cetuximab following nebulization.

Maillet A, Congy-Jolivet N, Le Guellec S, Vecellio L, Hamard S, Courty Y, Courtois A, Gauthier F, Diot P, Thibault G, Lemarié E, Heuzé-Vourc'h N.

Pharm Res. 2008 Jun;25(6):1318-26.

PMID:
18030605
36.

Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).

Blanchon T, Bréchot JM, Grenier PA, Ferretti GR, Lemarié E, Milleron B, Chagué D, Laurent F, Martinet Y, Beigelman-Aubry C, Blanchon F, Revel MP, Friard S, Rémy-Jardin M, Vasile M, Santelmo N, Lecalier A, Lefébure P, Moro-Sibilot D, Breton JL, Carette MF, Brambilla C, Fournel F, Kieffer A, Frija G, Flahault A; Dépiscan Group.

Lung Cancer. 2007 Oct;58(1):50-8. Epub 2007 Jul 12.

PMID:
17624475
37.

[Recommendations for nebulizer therapy].

Diot P, Zarka V, Lemarié E.

Rev Mal Respir. 2002 Feb;19(1):87-9. French. No abstract available.

PMID:
17546818
38.

[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer].

Westeel V, Lebitasy MP, Mercier M, Girard P, Barlesi F, Blanchon F, Tredaniel J, Bonnette P, Woronoff-Lemsi MC, Breton JL, Azarian R, Falcoz PE, Friard S, Geriniere L, Laporte S, Lemarie E, Quoix E, Zalcman G, Guigay J, Morin F, Milleron B, Depierre A; Intergroupe Francophone de Cancerologie Thoracique (IFCT).

Rev Mal Respir. 2007 May;24(5):645-52. French.

PMID:
17519819
39.

[Clinical types of thoracic cancer. Mediastinal tumours].

Lemarié E.

Rev Mal Respir. 2006 Nov;23(5 Pt 3):16S170-16S176. Review. French.

PMID:
17268355
40.

[Evidence based medicine. The facts in the North countries].

Lemarié E.

Rev Mal Respir. 2006 Sep;23(4 Pt 2):10S9-10S12. French. No abstract available.

PMID:
17127953
41.

Comparative analysis of different scintigraphic approaches to assess pulmonary ventilation.

Magnant J, Vecellio L, de Monte M, Grimbert D, Valat C, Boissinot E, Guilloteau D, Lemarié E, Diot P.

J Aerosol Med. 2006 Summer;19(2):148-59.

PMID:
16796539
42.

[Inhalation therapy].

None LV, Lemarié E, Diot P.

Rev Infirm. 2006 Feb;(118):16-23. Review. French. No abstract available.

PMID:
16562547
43.

[Radiological screening for lung cancer].

Lemarié E.

Rev Mal Respir. 2005 Dec;22(6 Pt 2):8S9-14. Review. French.

PMID:
16340830
44.

Gemcitabine aerosol: in vitro antitumor activity and deposition imaging for preclinical safety assessment in baboons.

Gagnadoux F, Leblond V, Vecellio L, Hureaux J, Le Pape A, Boisdron-Celle M, Montharu J, Majoral C, Fournier J, Urban T, Diot P, Racineux JL, Lemarié E.

Cancer Chemother Pharmacol. 2006 Aug;58(2):237-44. Epub 2005 Nov 19.

PMID:
16328414
45.

Aerosol delivery of chemotherapy in an orthotopic model of lung cancer.

Gagnadoux F, Pape AL, Lemarié E, Lerondel S, Valo I, Leblond V, Racineux JL, Urban T.

Eur Respir J. 2005 Oct;26(4):657-61.

46.

[Lympho-epithelial thymoma revealed by a cardiac tamponade].

Genée O, Dumont P, Champagne De Labriolle A, Pacouret G, Lemarié E, Charbonnier B.

Arch Mal Coeur Vaiss. 2005 Jun;98(6):680-3. French.

PMID:
16007825
47.

Safety of pulmonary administration of gemcitabine in rats.

Gagnadoux F, Le Pape A, Urban T, Montharu J, Vecellio L, Dubus JC, Leblond V, Diot P, Grimbert D, Racineux JL, Lemarié E.

J Aerosol Med. 2005 Summer;18(2):198-206.

PMID:
15966774
48.

[Evidence based pneumology: 3rd update workshop to the SPLF. Diagnosis of pleurisy (except cancer)].

Magro P, Ferrandière M, Hazouard E, Lemarié E, Rabbat A.

Rev Mal Respir. 2004 Dec;21(6 Pt 1):1191-6. Review. French. No abstract available.

PMID:
15793892
49.

[Evidence based pneumology: 3rd update workshop to the SPLF. Management of spontaneous and primary pneumothorax].

Rabbat A, Hazouard E, Magro P, Lemarié E.

Rev Mal Respir. 2004 Dec;21(6 Pt 1):1187-90. Review. French. No abstract available.

PMID:
15793891
50.

[Dyspnea and morphine aerosols in the palliative care of lung cancer].

Grimbert D, Lubin O, de Monte M, Vecellio None L, Perrier M, Carré P, Lemarié E, Boissinot E, Diot P.

Rev Mal Respir. 2004 Dec;21(6 Pt 1):1091-7. French.

PMID:
15767953

Supplemental Content

Loading ...
Support Center